David A. Hafler's research lab at Yale University focuses on understanding the immune system, particularly how T cells function in the context of autoimmune diseases and cancers like glioblastoma. They explore the roles of co-inhibitory pathways, especially TIGIT and PD-1, in regulating immune responses, aiming to develop innovative therapies to treat diseases caused by immune system dysfunction. The lab conducts both basic and translational research, integrating animal models and clinical trials to advance our understanding of immune mechanisms and identify new treatment strategies.

Dr. Amy F.T. Arnsten's lab at Yale University studies how stress affects the brain, particularly the areas responsible for memory and decision-making. By focusing on specific norepinephrine receptors, the research aims to understand why current treatments for disorders like PTSD and schizophrenia may not work for everyone. The ultimate goal is to find better therapeutic options that can improve cognitive function during stress-related challenges.

Alvaro Duque's lab at Yale focuses on studying the macaque brain, which is closely related to human brains, to understand brain development, function, and disease better. They maintain a unique collection of brain tissues from macaques that ranges from embryos to adults, allowing researchers to study various aspects of neuroscience without having to use more animals in experiments. This resource aims to promote research while ensuring ethical practices in animal studies.

The lab led by Dr. Jean-Leon Thomas at Yale University focuses on understanding how specialized blood vessels in the brain called meningeal lymphatic vessels influence the immune system during early development. The research emphasizes the relationship between these vessels and neuroimmune communication, particularly in relation to pediatric brain tumors like medulloblastoma. By utilizing advanced imaging techniques and genetic mouse models, the lab aims to uncover how these vessels can enhance T cell education and potentially improve treatments for childhood cancers.

Dr. Jesse Cedarbaum's research lab focuses on understanding and treating neurodegenerative diseases, particularly those related to synucleinopathies, like Parkinson's disease. The lab conducts clinical trials exploring the effectiveness of anti-TNF therapies to slow the progression of symptoms in patients with REM Sleep Behavior Disorder. By integrating advanced imaging techniques and immunological assessments, the team aims to uncover new insights into the inflammatory processes that may drive these disorders.

Dr. Jaime Grutzendler's lab focuses on understanding how two types of brain cells, microglia and astrocytes, interact in the context of Alzheimer's disease. The lab is investigating the protective roles these cells may play in wrapping around amyloid plaques, which are harmful clumps found in the brains of Alzheimer's patients. By using advanced imaging techniques, the researchers aim to uncover cellular interactions that could lead to new therapeutic strategies to protect neurons in Alzheimer's disease.

Dr. Clemens R. Scherzer's lab at Yale University focuses on understanding how genetic factors contribute to the progression of Parkinson's disease, particularly in relation to cognitive decline and dementia. The research aims to identify specific genetic markers that can predict the risk of developing dementia in Parkinson's patients, which could change how we approach treatment and management of the disease. By analyzing data from a large number of patients over time, the lab seeks to improve clinical outcomes for individuals affected by Parkinson's disease.

Dr. Jennifer A. Kim's research lab focuses on tackling post-traumatic epilepsy, a condition impacting many individuals recovering from traumatic brain injuries. By leveraging advanced data analysis techniques, including machine learning and neuroimaging, the lab aims to develop automated tools for predicting who is at risk for developing epilepsy after injury. This work could significantly improve patient outcomes by enabling early interventions based on individual risk factors.

The lab led by Pasko Rakic at Yale University focuses on understanding how the primate cerebral cortex develops, especially the prefrontal cortex associated with cognitive disorders and addiction. By studying non-human primate models, the research aims to uncover key genetic and molecular mechanisms that drive cortical expansion and differentiation, which could inform treatments for cognitive impairments in humans. This work is notable for its implications in both theoretical neuroscience and clinical settings.

Dr. Srikant Rangaraju's lab at Yale University focuses on understanding the role of microglia, the brain's immune cells, in Alzheimer's disease (AD). By studying the proteins produced by these cells, the lab aims to uncover how neuroinflammation contributes to AD pathology and develop new biomarkers that can aid in diagnosis and treatment. They utilize innovative techniques like ciBONCAT to analyze protein changes in living models, providing fresh perspectives on this complex disease.

Dr. Nenad Sestan's lab at Yale University focuses on understanding how the brain's cellular diversity affects aging and Alzheimer's disease. They study how specific cells in the hippocampal and entorhinal regions of the brain respond to Alzheimer's pathology and explore the molecular mechanisms behind this process. By employing advanced sequencing techniques, the lab aims to uncover patterns that may lead to better insights and treatments for Alzheimer's disease.

The research lab led by Dr. Serena Spudich focuses on understanding how HIV affects the central nervous system (CNS) and contributes to cognitive and mental health issues in individuals living with HIV. They use advanced techniques to study HIV persistence in the brain, particularly in individuals on antiretroviral therapy (ART), and investigate how the immune response and viral characteristics relate to neuropsychiatric outcomes. This work aims to uncover new therapies that can enhance mental health for people living with HIV.

Dr. Stephen Strittmatter's lab at Yale University focuses on understanding the mechanisms of synapse loss in Alzheimer's disease. The research investigates how a specific receptor in the brain, called mGluR5, contributes to the disease's progression and memory impairment. By using advanced imaging techniques and genetic models, the lab aims to discover new therapeutic approaches to prevent synapse loss and improve brain function in Alzheimer's patients.

Dr. Pooja Khatri's lab at Yale University focuses on understanding how to better predict recovery outcomes for patients who have suffered a stroke, particularly concerning their upper extremity function. They are investigating the use of advanced imaging techniques and brain stimulation to identify patients who will benefit from specific treatments in the early stages after a stroke. This research aims to enhance personalized rehabilitation strategies for improving motor function in stroke survivors.

Dr. Hal Blumenfeld's lab at Yale University focuses on understanding how subcortical brain systems influence our perception across different senses like sight, sound, and touch. By analyzing brain activity during sensory experiences, they explore how transient increases in brain activity can enhance our awareness of these stimuli. Their research aims to uncover fundamental neural circuits that could help improve therapies for cognitive disorders that impair perception.

Daniel A Colon-Ramos' lab at Yale University focuses on understanding the biology of synapses, which are crucial for communication between nerve cells and play a key role in how we learn and remember. The lab explores how synapses are formed and modified during development and learning, aiming to uncover the principles that govern behavior through neural circuitry. Their research not only deepens our understanding of basic neuroscience but also sheds light on conditions like neurodegeneration and disorders of brain development.

Dr. Shyam S Krishnakumar's lab focuses on understanding the complex mechanisms of synaptic transmission, particularly the roles of proteins like Complexin and Synaptotagmin in neurotransmitter release. They use a variety of experimental approaches, including studies in model organisms such as worms and mice, to explore how these proteins interact and regulate synapse function. Their research may provide insights into neurological disorders by enhancing our understanding of synaptic exocytosis.

Dr. Kevin Navin Sheth's lab focuses on improving the accessibility and effectiveness of brain imaging and treatment for stroke patients. They are developing a portable low-field MRI to allow for real-time imaging in acute care settings, which can enhance clinical decision making. Additionally, the lab is investigating the use of anticoagulant therapy in patients who have experienced an intracerebral hemorrhage, aiming to improve patient outcomes and reduce the risk of subsequent strokes.

Dr. Yuval Kluger’s lab at Yale University focuses on understanding how opioid use disorder (OUD) and HIV affect the brain’s cellular functions. The team utilizes advanced techniques to analyze brain tissue samples to uncover molecular changes and interactions between these two conditions, which are currently not well understood. Their goal is to identify potential targets for new treatments that can address the combined impact of OUD and HIV on the nervous system.

Dr. Rui Chang's lab at Yale University focuses on understanding how the brain senses signals from the body's internal organs through the vagus nerve. Using advanced molecular and genetic techniques, the lab investigates the architecture and functioning of this vital communication pathway. Their research aims to reveal how different visceral inputs are encoded and processed, paving the way for new insights into health and disease related to interoception, or the sense of the internal state of the body.